Olaf Walter
Lachen, SZ, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
Journal: European journal of haematology
Published: March 17, 2023
Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: August 20, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.
Journal: Thrombosis and haemostasis
Published: February 13, 2021
Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.
Journal: Therapeutic advances in hematology
Published: October 10, 2018
Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 10, 2018
Predictors of health-related quality of life in chronically ill children and adolescents over time.
Journal: Journal of psychosomatic research
Published: November 09, 2017
The validation of a computer-adaptive test (CAT) for assessing health-related quality of life in children and adolescents in a clinical sample: study design, methods and first results of the Kids-CAT study.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: October 12, 2016
Implementation of the Kids-CAT in clinical settings: a newly developed computer-adaptive test to facilitate the assessment of patient-reported outcomes of children and adolescents in clinical practice in Germany.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: December 15, 2015
A new recombinant factor VIII: from genetics to clinical use.
Journal: Drug design, development and therapy
Published: August 01, 2015
Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line.
Journal: Protein expression and purification
Published: May 28, 2015
The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics.
Journal: European journal of haematology
Published: May 09, 2012
Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII.
Journal: Thrombosis research
Published: February 29, 2012
Last Updated: 09/26/2026